首页> 外文OA文献 >Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome

【2h】

Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome

机译：散射大B细胞淋巴瘤在侵袭性非霍奇金淋巴瘤（PATEL）试验中的正电子发射断层扫描治疗中的分子特征：与临时宠物和结果相关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Julia Richter; Andreas Hüttmann; Jan Rekowski; Christine Schmitz; Selina Gärtner; Andreas Rosenwald; Martin-Leo Hansmann; Sylvia Hartmann; Peter Möller; Hans-Heinrich Wacker; Alfred Feller; Christoph Thorns; Stefan Müller; Ulrich Dührsen; Wolfram Klapper;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome [J] . Julia Richter, Andreas Hüttmann, Jan Rekowski, Blood cancer journal. . 2019,第9期

机译：散射大B细胞淋巴瘤在侵袭性非霍奇金淋巴瘤（PATEL）试验中的正电子发射断层扫描治疗中的分子特征：与临时宠物和结果相关
2. Interim PET-Based Outcome Prediction in Diffuse Large B-Cell Lymphoma Patients Participating in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) Trial: Comparison of the Delta SUV Max Method and the Deauville 5-Point Scale [J] . Rekowski Jan, Huettmann Andreas, Schmitz Christine, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：缺陷大型B细胞淋巴瘤患者的临时宠物基于宠物的结果预测参加正电子爆震断层摄影引导治疗的侵袭性非霍格金淋巴瘤（PATEL）试验：DELTA SUV MAX方法和Deauville 5分尺度的比较
3. Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial [J] . Huettmann Andreas, Rekowski Jan, Mueller Stefan P., Annals of hematology . 2019,第4期

机译：六剂与八个剂量的Rituximab患者患者接受六个循环的斩波：结果来自“积极的非霍奇金淋巴瘤的正电子发射断层摄影治疗”（Petal）试验
4. Prediction of diffuse large B-cell lymphoma outcome based on genes' analysis by use of SOM [C] . Furukawa, M., Watanabe, . 2005

机译：基于SOM基因分析的弥漫性大B细胞淋巴瘤预后预测
5. Effectiveness of Novel Immunotherapy and Chemotherapy Treatments for Follicular and Diffuse Large B-Cell Lymphomas [D] . Butsenko, Dmitriy. 2017

机译：新型免疫疗法和化学疗法对滤泡性和弥漫性大B细胞淋巴瘤的疗效
6. Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome [O] . Julia Richter, Andreas Hüttmann, Jan Rekowski, 2019

机译：正电子发射断层扫描引导性侵略性非霍奇金淋巴瘤（PETAL）试验中弥漫性大B细胞淋巴瘤的分子特征：与中期PET和预后的相关性
7. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-Cell Non-Hodgkin’s lymphoma1,2 1Expert panel members and authors of the review are: Theresa Hahn, PhD, Roswell Park Cancer Institute, Buffalo, NY; Steven N. Wolff, MD, Vanderbilt University, Nashville, TN, Myron Czuczman, MD, Roswell Park Cancer Institute, Buffalo, NY; Richard I. Fisher, MD, Cardinal Bernardin Cancer Center, Loyola University, Chicago, IL; Hillard M. Lazarus, MD, Comprehensive Cancer Center, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH; Philip L. McCarthy, MD, Roswell Park Cancer Institute, Buffalo, NY; Julie Vose, MD, University of Nebraska Medical Center, Omaha, NE; Lisa Warren, Cure for Lymphoma Foundation, New York, NY; and Richard Watt, MD, United Resource Networks, Minneapolis, MN. 2Reference: Hahn T, Wolff SN, Czuczman M, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma: an evidence-based review. Biol Blood Marrow Transplant. 2001;7:308–331. [O] . 2003

机译：造血干细胞移植的细胞毒性治疗在治疗弥漫性大细胞B细胞非霍奇金淋巴瘤1,2中的作用1，专家小组成员和评价的作者是：纽约州布法罗罗斯威尔公园癌症研究所的特蕾莎·哈恩博士；田纳西州纳什维尔范德比尔特大学医学博士斯蒂芬·沃尔夫（Steven N. Wolff），纽约州布法罗罗斯维尔公园癌症研究所医学博士迈伦·库兹曼（Myron Czuczman）；理查德·费舍尔（Richard I. Fisher）医学博士，伊利诺伊州芝加哥洛约拉大学贝纳尔丁枢机主教癌症中心；俄亥俄州克利夫兰凯斯西储大学克利夫兰大学医院综合癌症中心医学博士Hillard M. Lazarus；纽约州布法罗罗斯韦尔公园癌症研究所医学博士Philip L.内布拉斯加州奥马哈市内布拉斯加大学医学中心医学博士Julie Vose；丽莎·沃伦（Lisa Warren），纽约州纽约市淋巴瘤基金会的治疗；和明尼苏达州明尼阿波利斯市联合资源网络公司的医学博士Richard Watt。 2参考文献：Hahn T，Wolff SN，Czuczman M等。一项基于证据的综述：造血干细胞移植的细胞毒性治疗在弥漫性大细胞B细胞非霍奇金淋巴瘤治疗中的作用。 Biol骨髓移植。 2001; 7：308-331。

Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome

著录项

引文网络

相似文献

相关主题

期刊订阅